CK

Chintan Kantibhai Patel

Active Director Designated Partner DIN 06970815
DIN 06970815 First appointment Nov 2014 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Chintan Kantibhai Patel

Data last updated:

Chintan Kantibhai Patel is a Designated Partner at Igenius Life Science Llp (since 2014). The company operates in Pharma.

DIN 06970815
Primary Designation Designated Partner
Industry Pharma
First Appointment 18 Nov 2014
Oldest Company Age 12 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner18 Nov 20142014Active

Board colleagues of Chintan Kantibhai Patel

Directorship timeline

Open interactive timeline →
Igenius Life Science Llp
Premium access

Shareholding and investment profile for Chintan Kantibhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chintan Kantibhai Patel

Chintan Kantibhai Patel currently holds 1 directorship: Igenius Life Science Llp (Designated Partner, since 18 Nov 2014).

Chintan Kantibhai Patel was first appointed on 18 Nov 2014 as Designated Partner at Igenius Life Science Llp.

The current boards of Chintan Kantibhai Patel's companies include Manish Gopalbhai Patel (Igenius Life Science Llp), Minesh Manharlal Suthar (Igenius Life Science Llp), Pravinbhai Narshibhai Patel (Igenius Life Science Llp), Raxit Chandrakantbhai Patel (Igenius Life Science Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available